THE EFFECTIVENESS OF EARLY ANTIVIRAL THERAPY IN REDUCING COVID-19 SEVERITY
Fuente:
Zenodo
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | inglés |
| Publicado: |
Zenodo
2026
|
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866902099817660416 |
|---|---|
| author | Jevana D Riagup K |
| author_facet | Jevana D Riagup K |
| contents | <p class="MsoNormal">The global outbreak of COVID-19 has led to a critical need for effective therapeutic strategies. Among these, early administration of antiviral agents such as remdesivir and molnupiravir has shown potential to reduce disease severity and improve clinical outcomes. This study investigates the clinical impact of initiating antiviral therapy during the early phase of SARS-CoV-2 infection, focusing on hospitalization rates, ICU admissions, and mortality.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20343802 |
| institution | Zenodo |
| language | eng |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | THE EFFECTIVENESS OF EARLY ANTIVIRAL THERAPY IN REDUCING COVID-19 SEVERITY Jevana D Riagup K <p class="MsoNormal">The global outbreak of COVID-19 has led to a critical need for effective therapeutic strategies. Among these, early administration of antiviral agents such as remdesivir and molnupiravir has shown potential to reduce disease severity and improve clinical outcomes. This study investigates the clinical impact of initiating antiviral therapy during the early phase of SARS-CoV-2 infection, focusing on hospitalization rates, ICU admissions, and mortality.</p> |
| title | THE EFFECTIVENESS OF EARLY ANTIVIRAL THERAPY IN REDUCING COVID-19 SEVERITY |
| url | https://doi.org/10.5281/zenodo.20343802 |